Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2014, Article ID 361748, 3 pages
http://dx.doi.org/10.1155/2014/361748
Case Report

MYST3/CREBBP Rearranged Acute Myeloid Leukemia after Adjuvant Chemotherapy for Breast Cancer

1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
2Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA
3Department of Hematology Oncology, University of Texas Southwestern Medical Center, Seay Biomedical Building, 2201 Inwood Road, Dallas, TX 75390, USA

Received 29 October 2014; Accepted 20 November 2014; Published 8 December 2014

Academic Editor: Sercan Aksoy

Copyright © 2014 Arjun Gupta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Gervais, A. Murati, C. Helias et al., “Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique,” Leukemia, vol. 22, no. 8, pp. 1567–1575, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Haferlach, A. Kohlmann, H.-U. Klein et al., “AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features,” Leukemia, vol. 23, no. 5, pp. 934–943, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Borrow, V. P. Stanton Jr., J. M. Andresen et al., “The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein,” Nature Genetics, vol. 14, no. 1, pp. 33–41, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. H. H. Schmidt, “MYST3/CREBBP (MOZ/CBP) and CREBBP/MYST3 (CBP/MOZ) transcripts in AML with t(8;16)(p11;p13),” Genes, Chromosomes & Cancer, vol. 42, no. 2, pp. 207–208, 2005. View at Google Scholar
  5. S. Heim, G.-C. Avanzi, R. Billstrom et al., “A new specific chromosomal rearrangement, t(8;16) (p11;p13), in acute monocytic leukaemia,” British Journal of Haematology, vol. 66, no. 3, pp. 323–326, 1987. View at Publisher · View at Google Scholar · View at Scopus
  6. X.-J. Yang and M. Ullah, “MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells,” Oncogene, vol. 26, no. 37, pp. 5408–5419, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Dharmasena, N. Wickham, P. J. McHugh, D. Catovsky, and D. A. Galton, “Osteolytic tumors in acute megakaryoblastic leukemia,” Cancer, vol. 58, no. 10, pp. 2273–2277, 1986. View at Google Scholar
  8. P. A. Kosmidis, C. G. Palacas, and A. R. Axelrod, “Diffuse purely osteolytic lesions in myelofibrosis,” Cancer, vol. 46, no. 10, pp. 2263–2265, 1980. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Beadle, P. Baade, and L. Fritschi, “Acute myeloid leukemia after breast cancer: a population-based comparison with hematological malignancies and other cancers,” Annals of Oncology, vol. 20, no. 1, pp. 103–109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. A. Patt, Z. Duan, S. Fang, G. N. Hortobagyi, and S. H. Giordano, “Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk,” Journal of Clinical Oncology, vol. 25, no. 25, pp. 3871–3876, 2007. View at Publisher · View at Google Scholar · View at Scopus